Compare ON & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ON | BDX |
|---|---|---|
| Founded | 1992 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.9B | 43.0B |
| IPO Year | 2000 | 1997 |
| Metric | ON | BDX |
|---|---|---|
| Price | $92.73 | $154.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 25 | 13 |
| Target Price | $65.29 | ★ $186.00 |
| AVG Volume (30 Days) | ★ 13.1M | 2.3M |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.89% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | $5,878,300,000.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $7.93 | N/A |
| Revenue Next Year | $8.90 | $3.02 |
| P/E Ratio | ★ N/A | $604.02 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $44.56 | $140.11 |
| 52 Week High | $134.92 | $213.08 |
| Indicator | ON | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 42.40 | 55.71 |
| Support Level | $51.30 | $153.27 |
| Resistance Level | $133.67 | $159.72 |
| Average True Range (ATR) | 5.47 | 4.14 |
| MACD | -0.68 | 0.05 |
| Stochastic Oscillator | 18.33 | 61.84 |
Onsemi is a supplier of power semiconductors and sensors focused on the automotive and industrial markets. Onsemi is the second-largest power chipmaker in the world and the largest supplier of image sensors to the automotive market. While the firm used to be highly vertically integrated, it now pursues a hybrid manufacturing strategy for flexible capacity. Onsemi is pivoting to focus on emerging applications like electric vehicles, autonomous vehicles, industrial automation, and renewable energy.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.